Talking Biotech with Dr. Kevin Folta
Colabra
All episodes
Best episodes
Top 10 Talking Biotech with Dr. Kevin Folta Episodes
Goodpods has curated a list of the 10 best Talking Biotech with Dr. Kevin Folta episodes, ranked by the number of listens and likes each episode have garnered from our listeners. If you are listening to Talking Biotech with Dr. Kevin Folta for the first time, there's no better place to start than with one of these standout episodes. If you are a fan of the show, vote for your favorite Talking Biotech with Dr. Kevin Folta episode by adding your comments to the episode page.
Trish Jordan: Hollywood and the Percy Schmeiser Story
Talking Biotech with Dr. Kevin Folta
01/29/22 • 52 min
The story of Percy Schmeiser is a well known tale of big biotech against the little farmer from rural Saskatchewan. Schmeiser grew canola, and his outstanding harvests were due to herbicide tolerant seeds that he grew himself from materials obtained from means other than purchase. This violation of patent rights became the fodder of activist organizations, and a test of how a large company would respond to an unlicensed use of their technology. Schmeiser became the darling of anti-GMO activists, and he became the figurehead of a conversation about technology, patents, farmers’ rights, and seed sovereignty. This week’s podcast analyzes the film Percy vs. Goliath, a film that attempts to tell Schmeiser’s story. But what was accurate and what was fictionalized in the film? I spoke with Trish Jordan, who at the time was a communications lead at the Monsanto Corporation and followed the story very closely. She had a front-row seat for the legal proceedings and provides her analysis of the film’s veracity.
Follow Trish on Twitter: @AggieCoolChick
IMDB page for Percy vs. Goliath
# COLABRA
Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/
# TALKING BIOTECH
Twitter: https://twitter.com/talkingbiotech
Website: https://www.colabra.app/podcasts/talking-biotech/
Instagram: https://www.instagram.com/colabrahq
The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.
Collateral Neonic Impacts
Talking Biotech with Dr. Kevin Folta
07/08/17 • 44 min
Neonicotinoids (neonics) are a class of insecticides based on natural plant compounds that disrupt the insect nervous system. They are used because they have relatively low toxicity on non-insects. They are applied as seed coatings, so when a seed germinates the water-soluble insecticides are taken up and mobilized throughout the plant, providing protection against insects that feed on it. The strategy decreases the need for aerial spraying of broad-spectrum insecticides.
Because of these attributes, neonic use has increased significantly. As usual, when a single strategy is employed there can be collateral effects. Dr. John Tooker from Penn State University describes his work on today’s podcast. Dr. Tooker examines a situation where the reliance on neonics has led to problems with other pests. This reminds us that integrated pest management is important, that there are no one-size-fits-all solutions, and that we have to exercise care in monitoring unanticipated effects of insecticide use.
Dr. Tooker’s website
Follow on Twitter: @jftooker
# COLABRA
Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/
# TALKING BIOTECH
Twitter: https://twitter.com/talkingbiotech
Website: https://www.colabra.app/podcasts/talking-biotech/
Instagram: https://www.instagram.com/colabrahq
The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.
Genetically Modified Mosquito Control – Careers in Plant Breeding
Talking Biotech with Dr. Kevin Folta
08/15/15 • 80 min
This week’s podcast discusses Kevin Folta’s public records situation for 60 seconds.
That is followed by a talk with Dr. Andrew McKemey from Oxitec in Oxford, England. Oxitec has a technology that allows rearing of male mosquitoes that transmit a gene that disrupts offspring from developing. This technology has been show to work field situations, providing potential solutions to mosquito-borne disease. Dr. McKemey describes the technology and addresses ecological concerns.
In the second part Dr. Phil Stewart from Driscoll’s Strawberry Associates talks about careers in plant breeding. There is a desperate need for plant breeders in both industry and academia. These high-paying, satisfying careers outnumber the supply of graduating students to fill the positions. Dr. Stewart discusses his job, the required preparations, and how interested students can target these lucrative and fulfilling career paths.
# COLABRA
Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/
# TALKING BIOTECH
Twitter: https://twitter.com/talkingbiotech
Website: https://www.colabra.app/podcasts/talking-biotech/
Instagram: https://www.instagram.com/colabrahq
The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.
The Risks of Manufactured Viruses - Dr. Kevin Esvelt
Talking Biotech with Dr. Kevin Folta
01/14/23 • 58 min
What are the risks associated with being able to create custom DNA? Today's podcast discusses the potential weaponization of synthesized nucleic acid sequences. Dr. Kevin Esvelt discusses synthetic DNA and synthetic viruses, along with the possibility that they may drive the next pandemics or become the basis for future biological weapons. The dark realities are discussed, along with surveillance and mitigation strategies, as well as the broken social trust that could fuel a human-made pandemic.
The Psychology of Risk - Dr. Felicia Wu
Talking Biotech with Dr. Kevin Folta
04/20/24 • 41 min
We live in amazing times of technological advance, but how are the real benefits of new tech lost to an inflated sense of risk? Dr. Felicia Wu from Michigan State University shares her expertise in describing the psychological basis of risk and applying it to questions like glyphosate and aspartame.
New Cancer Drugs: Breaking the Cell Cycle -- Spiro Rombotis
Talking Biotech with Dr. Kevin Folta
12/17/22 • 36 min
The "cell cycle" describes discrete steps in the process of cell division. The progression is mediated by a series of gatekeeping biochemical activities that ensure complete replication of DNA, and surveil it for fidelity. Precise execution of cell cycle is necessary for normal growth and development. At the same time, loss of cell cycle coordination can lead to aberrant cell proliferation that can become genetically unstable, a condition recognized as cancer. Many drugs target the enzymes that control cell cycle progression, and several appear to be attractive candidates for future therapeutics. Spiro Rombotis of Cyclacel Pharmaceuticals describes targeting the cell cycle, along with new drugs that show promise in slowing, arresting, or possibly reversing some challenging subtypes of cancers.
Special Panel - From Pre-Clinical to Clinical Trials
Talking Biotech with Dr. Kevin Folta
06/15/24 • 33 min
Advancement of a new drug from pre-clinical trials to clinical trials is a pivotal time in validation of its therapeutic effects and safety. A panel of experts discusses the process.
The Story of GE Papaya, Helping People Save an Industry
Talking Biotech with Dr. Kevin Folta
03/05/16 • 82 min
The story of how genetic engineering saved the Hawaiian papaya industry gets lost in the discussion of agronomic crop uses of the technology. This story is important because this is not just a story of technology. It is the story of people.
Joni Kamiya tells the story of growing up on her family’s farm and the changes that came with the virus and how the genetically engineered saved production of this traditional crop for their family.
Follow Joni on Twitter at @HIFarmersDtr, and her blog at hawaiifarmersdaughter.com
The second part of the podcast visits with Cornell plant virologist Dr. Dennis Gonsalves. He studied papaya ringspot virus in the 1970’s and 1980’s, designing clever solutions to treat the disease that plagued the industry in his home state. Into the 1990’s he teamed with others working in genetic engineering to develop a solution for papaya. While the first half of his interview is about the disease and the techniques used to solve it, the second half is about the satisfaction of being a kid growing up, going to university, studying under brilliant and kind supervisors that taught him to think about science, but to also think about people.
This is a wonderful interview with a warm and charming wayward Hawaiian boy that returned home to rescue an small-farmers growing a traditional crop in the place he loves. He also touches on how activists derail technology deployment, and how public-sector scientists need to step up in efforts to create products and engage the public.
# COLABRA
Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/
# TALKING BIOTECH
Twitter: https://twitter.com/talkingbiotech
Website: https://www.colabra.app/podcasts/talking-biotech/
Instagram: https://www.instagram.com/colabrahq
The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.
Trees that Survive Citrus Greening - Gary England
Talking Biotech with Dr. Kevin Folta
10/19/24 • 50 min
Citrus greening disease or HLB has severely impacted Florida citrus production. And while many solutions have been proposed, there is interest in a number of trees that have shown to not show symptoms of the disease. This week's episode discusses the disease with retired extension specialist Gary England as he evaluates "survivor" trees. These trees continue to produce even when infected, and may provide insights into resistance to the disease, as well as provide genetics to maintain the Florida orange juice industry until other options are available.
The GalSafe Pig and Xenotransplantation
Talking Biotech with Dr. Kevin Folta
04/24/21 • 37 min
Last week’s episode covered Alpha Gal Syndrome, the tick-induced allergy to beef and pork. The same immunological response could also limit a recipient’s access to xenography or xenotransplantation, that is, the introduction of pig and cow tissues and organs for human benefit. From valves to tendons to organs, the use of non-human animal parts is becoming increasingly common, but so is the instance of immune response to them due to a response to alpha gal. Today’s guest is Dr. John Bianchi, VP of Product Development at Revivicor. Revivicor has developed the GalSafe Pig, a genetic engineering step that eliminates the production of Alpha-Gal, making organs compatible with sensitive recipients. While solving the key problem of xenographic transplants and tissue donation, the pork may also be consumed without incident. Again science rises to solve an important problem.
# COLABRA
Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/
# TALKING BIOTECH
Twitter: https://twitter.com/talkingbiotech
Website: https://www.colabra.app/podcasts/talking-biotech/
Instagram: https://www.instagram.com/colabrahq
The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.
Show more best episodes
Show more best episodes
FAQ
How many episodes does Talking Biotech with Dr. Kevin Folta have?
Talking Biotech with Dr. Kevin Folta currently has 518 episodes available.
What topics does Talking Biotech with Dr. Kevin Folta cover?
The podcast is about Life Sciences, Biotech, Podcasts, Science, Agriculture and Biology.
What is the most popular episode on Talking Biotech with Dr. Kevin Folta?
The episode title 'The Race to the COVID19 mRNA Vaccine' is the most popular.
What is the average episode length on Talking Biotech with Dr. Kevin Folta?
The average episode length on Talking Biotech with Dr. Kevin Folta is 44 minutes.
How often are episodes of Talking Biotech with Dr. Kevin Folta released?
Episodes of Talking Biotech with Dr. Kevin Folta are typically released every 6 days, 23 hours.
When was the first episode of Talking Biotech with Dr. Kevin Folta?
The first episode of Talking Biotech with Dr. Kevin Folta was released on Jul 11, 2015.
Show more FAQ
Show more FAQ